Use with PEGASYS/ribavirin and other HCV antivirals associated with hepatic decompensation (some fatal). Monitor closely for toxicities and consider dose reduction or discontinuation.
Source: NLP:peginterferon alfa-2a
1 interaction on record
Use with PEGASYS/ribavirin and other HCV antivirals associated with hepatic decompensation (some fatal). Monitor closely for toxicities and consider dose reduction or discontinuation.
Source: NLP:peginterferon alfa-2a